Feature|Podcasts|March 24, 2025
Tariffs and Drug Prices: Understanding the Impact on Pharmaceuticals
Author(s)Miranda Schmalfuhs
Peter Ax, founder & CEO of UpScriptHealth, discusses the impact of tariffs on the pharmaceutical industry and how digital health platforms could potentially help offset them.
Advertisement
In this Pharmaceutical Executive podcast episode, UpScriptHealth founder and CEO Peter Ax discusses:
- The impact of tariffs on the pharmaceutical industry, highlighting branded and generics medications
- How tariffs could lead to strategic supply chain changes, including potential US manufacturing shifts
- How digital health platforms can help potentially offset tariff impacts
- The importance of telehealth in ensuring medication availability
- Strategic partnerships between digital health platforms and pharma companies to improve patient care and access
- and more
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Relation Therapeutics Forms $1.7 Billion Multi-Program Collaboration with Novartis Advancing Therapeutics for Atopic Diseases
2
Pfizer Enters Exclusive Collaboration and License Agreement with Yao Pharma for Oral Small-Molecule GLP-1 Agonists
3
Carvykti Displays Sustained Remissions in Early Use for Relapsed or Refractory Multiple Myeloma
4
Eli Lilly’s Jaypirca Achieves Primary Endpoint in Head-to-Head Phase III Study Against Imbruvica Treating CLL/SLL
5
